Virtus LifeSci Biotech Clinical Trials ETF
12 hedge funds and large institutions have $3.71M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2016 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding in top 10
Funds holding in top 10: →
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Sellers
| 1 | -$971K | |
| 2 | -$945K | |
| 3 | -$158K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$27.6K |
| 5 |
Morgan Stanley
New York
|
-$7.59K |